{
  "metadata": {
    "input_documents": [
      "research_paper_1.pdf",
      "research_paper_2.pdf", 
      "research_paper_3.pdf",
      "research_paper_4.pdf"
    ],
    "persona": "PhD Researcher in Computational Biology",
    "job_to_be_done": "Prepare a comprehensive literature review focusing on methodologies, datasets, and performance benchmarks",
    "processing_timestamp": "2025-07-27T10:00:00.000000+00:00"
  },
  "extracted_sections": [
    {
      "document": "research_paper_1.pdf",
      "section_title": "Graph Neural Network Architecture for Drug Discovery",
      "importance_rank": 1,
      "page_number": 3
    },
    {
      "document": "research_paper_2.pdf", 
      "section_title": "Molecular Property Prediction Methodologies",
      "importance_rank": 2,
      "page_number": 5
    },
    {
      "document": "research_paper_3.pdf",
      "section_title": "Benchmark Datasets and Evaluation Metrics",
      "importance_rank": 3,
      "page_number": 7
    },
    {
      "document": "research_paper_4.pdf",
      "section_title": "Performance Comparison on Drug-Target Interaction",
      "importance_rank": 4,
      "page_number": 12
    },
    {
      "document": "research_paper_1.pdf",
      "section_title": "Related Work in Graph-based Drug Discovery",
      "importance_rank": 5,
      "page_number": 2
    }
  ],
  "subsection_analysis": [
    {
      "document": "research_paper_1.pdf",
      "refined_text": "We propose a novel graph convolutional neural network architecture specifically designed for molecular property prediction in drug discovery. Our approach integrates chemical bond information with atomic features to create comprehensive molecular representations. The network consists of multiple graph convolutional layers followed by a global pooling mechanism and fully connected layers for property prediction.",
      "page_number": 3
    },
    {
      "document": "research_paper_2.pdf",
      "refined_text": "Our methodology combines graph neural networks with attention mechanisms to predict molecular properties relevant to drug discovery. We utilize a dataset of 500,000 compounds with experimentally verified properties including solubility, toxicity, and bioactivity. The model achieves state-of-the-art performance with an RÂ² score of 0.87 on the test set.",
      "page_number": 5
    },
    {
      "document": "research_paper_3.pdf", 
      "refined_text": "We evaluate our approach on standard benchmark datasets including MoleculeNet, ChEMBL, and PubChem. Performance metrics include RMSE for regression tasks and ROC-AUC for classification tasks. Our method consistently outperforms baseline approaches across all datasets, demonstrating the effectiveness of graph neural networks for molecular property prediction.",
      "page_number": 7
    },
    {
      "document": "research_paper_4.pdf",
      "refined_text": "Comparative analysis reveals that graph neural network approaches achieve superior performance in drug-target interaction prediction compared to traditional machine learning methods. Our GNN model achieves 92% accuracy on the Davis kinase dataset and 89% accuracy on the KIBA dataset, representing significant improvements over existing methods.",
      "page_number": 12
    },
    {
      "document": "research_paper_1.pdf",
      "refined_text": "Previous work in graph-based drug discovery includes applications of graph convolutional networks, graph attention networks, and message passing neural networks. Early approaches focused on molecular fingerprint generation, while recent advances have explored end-to-end learning from molecular graphs for property prediction and drug design.",
      "page_number": 2
    }
  ]
}
